01 — The Text
What.
- Prohibits pharmacy benefit managers (PBMs)—middlemen between insurers and pharmacies—from accepting kickbacks or rebates tied to drug prices.
- Targets financial arrangements that incentivize PBMs to prefer expensive drugs over cheaper alternatives.
- Detailed policy mechanism unavailable; bill summary not yet published by Congressional Research Service.
02 — The Stakes
So what?
- Patients and insurers potentially pay less if PBMs can't profit from steering toward pricier medications.
- Large PBMs (CVS, Cigna, Anthem-owned entities) face stricter limits on revenue streams from pharmaceutical manufacturers.
- Small pharmacies and independent drug stores may benefit if kickback schemes no longer disadvantage them competitively.
03 — The Path
Now what?
- Bill passed House committee unanimously (34-0) in May 2026; now on Union Calendar awaiting full House floor vote.
- Next step: House floor debate and vote, then Senate consideration if passed.
- Contact your representative to ask their stance on PBM reform—measure has bipartisan support so far.
Legislative History
Actions.
- Jul 2, 2026 — Placed on the Union Calendar, Calendar No. 634.
- Jul 2, 2026 — Reported (Amended) by the Committee on Education and Workforce. H. Rept. 119-729.
- Jul 2, 2026 — Reported (Amended) by the Committee on Education and Workforce. H. Rept. 119-729.
- May 21, 2026 — Ordered to be Reported (Amended) by the Yeas and Nays: 34 - 0.
- May 21, 2026 — Committee Consideration and Mark-up Session Held
- Mar 12, 2026 — Referred to the House Committee on Education and Workforce.
- Mar 12, 2026 — Introduced in House
- Mar 12, 2026 — Introduced in House